Bahl & Gaynor’s PetMed Express PETS Stock Holding History

Bahl & Gaynor’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-113,861	Closed	-$2.27M	–	325
2022 Q2	$2.27M	Buy	113,861 +22,365	+24%	+$500K	0.01%	212
2022 Q1	$2.36M	Sell	91,496 -54,790	-37%	-$1.42M	0.02%	210
2021 Q4	$3.7M	Buy	146,286 +1,519	+1%	+$42K	0.02%	188
2021 Q3	$3.89M	Sell	144,767 -314	-0.2%	-$9.04K	0.02%	181
2021 Q2	$4.62M	Buy	145,081 +58,546	+68%	+$1.86M	0.03%	175
2021 Q1	$3.04M	Sell	86,535 -26,420	-23%	-$919K	0.02%	203
2020 Q4	$3.62M	Sell	112,955 -96	-0.1%	-$2.96K	0.02%	187
2020 Q3	$3.57M	Buy	113,051 +44,977	+66%	+$1.49M	0.03%	171
2020 Q2	$2.43M	Buy	+68,074	New	+$2.36M	0.02%	198
2017 Q2	–	Sell	-35,230	Closed	-$710K	–	406
2017 Q1	$710K	Buy	35,230 +740	+2%	+$15.7K	0.01%	288
2016 Q4	$796K	Buy	+34,490	New	+$739K	0.01%	263

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Bahl & Gaynor's PETS Position: Q3 2022 in Review

Bahl & Gaynor sold out of PetMed Express (PETS) in Q3 2022, closing a stake of 113,861 shares — an estimated $2.27M sold.

Bahl & Gaynor first reported a position in PETS in Q4 2016 and held it in 11 quarters. The position peaked at $4.62M in Q2 2021. 176 funds tracked by Wall St. Rank hold PETS as of Q3 2022.

Bahl & Gaynor reported no remaining PetMed Express position as of Q3 2022 after selling out during the quarter.
Bahl & Gaynor sold 113,861 PetMed Express shares in Q3 2022, an estimated $2.27M.
Bahl & Gaynor first reported a position in PetMed Express in Q4 2016 and held it in 11 quarters.
Bahl & Gaynor's PetMed Express position peaked at $4.62M in Q2 2021.
176 funds tracked by Wall St. Rank held PetMed Express as of Q3 2022.

Based on Bahl & Gaynor's 13F filing for Q3 2022, filed 14 Nov 2022.